Krista Krause
Family · Syracuse, NYNPI 1710473632
Payments from drug & device makers
Across 118 payments — averaging $17.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$369
- GSK$223
- Lilly USA, LLC$207
- Novo Nordisk$184
- Boehringer Ingelheim$139
- Bayer$97
- plus $794 from 20 others
What the payments were for
- Food & beverage$2,013100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 21 | $369 |
| GSK | 12 | $223 |
| Lilly USA, LLC | 14 | $207 |
| Novo Nordisk | 11 | $184 |
| Boehringer Ingelheim | 9 | $139 |
| Bayer | 5 | $97 |
| Acadia Pharmaceuticals Inc | 4 | $82 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $70 |
| Pfizer | 4 | $67 |
| Merck | 4 | $61 |
| Johnson & Johnson | 3 | $55 |
| AstraZeneca | 4 | $54 |
| Amarin Pharma, Inc. | 3 | $47 |
| VBI Vaccine (delaware) Inc. | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Idorsia Pharmaceuticals US Inc | 2 | $42 |
| Biohaven Pharmaceuticals, Inc. | 2 | $39 |
| Exact Sciences | 2 | $35 |
| Novartis | 2 | $31 |
| Neurocrine Biosciences, Inc. | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| Avanir Pharmaceuticals, Inc. | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
| Optinose US, Inc. | 1 | $13 |
How this compares
$2,013 in reported general payments places this provider in the 80th percentile of 8,883 family providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NuedextaDextromethorphan Hbr/Quinidine | 30 | $21,604 |
| EliquisApixaban | 35 | $15,435 |
| OzempicSemaglutide | 13 | $13,343 |
| XareltoRivaroxaban | 13 | $11,792 |
| Bydureon BciseExenatide Microspheres | 18 | $10,551 |
| FarxigaDapagliflozin Propanediol | 15 | $9,131 |
| TrulicityDulaglutide | 15 | $8,103 |
| Divalproex Sodium | 43 | $6,163 |
| Olanzapine OdtOlanzapine | 15 | $3,430 |
| Lacosamide | 30 | $2,980 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 108 | $2,905 |
| Pregabalin | 47 | $2,534 |
| Divalproex Sodium ErDivalproex Sodium | 13 | $1,703 |
| Mirtazapine | 47 | $1,582 |
| Tresiba Flextouch U-100Insulin Degludec | 13 | $1,424 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Avanir Pharmaceuticals, Inc.Nuedexta | $21 | $21,60430 claims |
| PfizerEliquis | $67 | $15,43535 claims |
| Novo NordiskOzempic | $184 | $13,34313 claims |
| Johnson & JohnsonXarelto | $55 | $11,79213 claims |
| AstraZenecaFarxiga | $54 | $9,13115 claims |
| Lilly USA, LLCTrulicity, Olanzapine | $207 | $8,35533 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,883 family providers in New York.
Other family in Syracuse
- Jonathan LesuerSyracuse$172K
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Suzanne WilsonIthaca$179K
- Sheri HillNorth Syracuse$165K
- Cathrine CurtinBronxville$155K
- Mary Sullivan-WhalenNew York$137K
- Sarah AljahmiRockville Centre$87K
- John de OcaStaten Island$86K
- Fara StrickerGlen Oaks$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.